Maynard Um
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $125 at Oppenheimer
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $129 at Canaccord
-
-
-
-
-
-
-
Kymera presents preclinical IBD data for oral IRF5 degrader KT-579
-
-
-
-
-
-
-
RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
-
-
-
-
-
-
-
Piper Sandler Assumes Kymera Therapeutics (KYMR) at Overweight
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $134 at H.C. Wainwright
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $138 at BTIG
-
456,169 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

